Williams & Connolly partner David Berl has been named “General Patent Litigator of the Year (D.C. Metro)” by LMG Life Sciences.  In the past year, David has been involved in several high-profile client victories, most notably his successful representation of Genevant in patent litigation relating to the COVID-19 vaccine, resulting in the second biggest lump-sum settlement in the history of patent litigation and the largest ever in the pharmaceutical industry.

David is Co-Chair of the firm’s Patent Litigation practice and focuses principally in the biotechnology, pharmaceutical, and energy fields.  He has served as lead counsel in numerous biotechnology and pharmaceutical patent trials, in appellate proceedings in the Court of Appeals for the Federal Circuit, and in inter partes review proceedings before the PTO.  He regularly serves as lead counsel to major corporations in significant patent litigations and has tried numerous patent cases that have resulted in verdicts favorable to his clients.  

To see the full list of winners, click here.